Open AccessSevere sinus bradycardia associated with favipiravir in a COVID‐19 patient
Author(s) -
Habib Mhd Baraa,
Elshafei Mohamed,
Rahhal Alaa,
Mohamed Mouhand F. H.
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4566
Subject(s) - medicine , covid-19 , bradycardia , favipiravir , sinus bradycardia , anesthesia , intensive care medicine , virology , heart rate , disease , infectious disease (medical specialty) , outbreak , blood pressure
The antiviral medication “favipiravir” should be considered as a possible cause of unexplained sinus bradycardia.